Enhancing the CRO-Sponsor Collaboration to Ensure High Quality of Clinical Data May 17,2011 | Beijing, China Charles Yan, PhD Shanghai Clinical Research.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Gakava L Roche Products Ltd., Welwyn, UK
Project Quality Plans Gillian Sandilands Director of Quality
Tips to a Successful Monitoring Visit
Roadmap for Sourcing Decision Review Board (DRB)
Ensure Vendor/Engineer of Choice Product Quality
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
ORGANIZATION. 2 Purchasing & Inventory Assessment Occurrence Management Information Management Process Improvement Customer Service Facilities & Safety.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
Cheryl McCarthy Manager, Quality Assurance MBC Session October 3, 2008 GCP Compliance in our Vendors.
EDC PHARMA SERVICES Capacity. Expertise. Solutions. Technology.
Laboratory Personnel Dr/Ehsan Moahmen Rizk.
| LUMIS International GmbH | Successful conduct of clinical trials to prove biosimilarity through defining a best fit outsourcing strategy Heike Schoen,
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
Using EDC-Rave to Conduct Clinical Trials at Genentech
Laura Cocking Senior Data Manager Peninsula Clinical Trials Unit A Trial Manager’s Guide to Data Management Exeter Clinical Trials Support Network Event.
Frequently Asked Questions. No, in fact DOCTUS considers itself a strategic extension of your organization. Hence, we deliver the work the way you do.
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Business Acquisition Process Implementation & transition Closing Negotiation of the transaction Due Diligence Engagement TargetIdentification.
Strategic Approaches to Outsourcing to Clinical Research Organizations Kate Giovino Director of Clinical Operations.
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems.
Healing Hands Clinical Research Services is a clinical Research Service Provider which has broad spectrum of.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Internal Auditing and Outsourcing
Project Management An Overview John Mulhall MIICM; LIB International Credit & Process Management Professional.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
Acquisitions, a Publisher’s Perspective Craig Duncan Development Manager External Development Studio Building the partnership between.
Quality Assurance in Bio-availability / Bio-equivalence studies. DR
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Contents Integrating clinical trial data Working with CROs
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
RAISING THE BAR Meeting CSA Guidelines And Preparing for Health Canada
Fourth Annual Medical Research Summit Concurrent Session 4.05 – Managing CROs and SMOs from a Compliance Perspective Michael SwiatochaAprill 23, 2004.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
ISO9001 Pre Assessment Team 10 PT Han Jian Da, Alphy Thomas Kanatt, Xia Xi, Wu Jun, May Lwin, Chit Khun, Mohit Srivastava, Kovalan Venkatesan.
SIPLAS RO is a full service contract research organization CRO, offering nanotechnology, biopharmaceutical and medical device companies comprehensive.
Week 2 Seminar: Project Scope Management
ISM 5316 Week 3 Learning Objectives You should be able to: u Define and list issues and steps in Project Integration u List and describe the components.
普 华 永 道 Phase 1: Project Preparation Phase 1: Project Preparation Phase Overview Phase Overview.
3 1 Project Success Factors u Project management important for success of system development project u 2000 Standish Group Study l Only 28% of system development.
Using EDC-Rave to Conduct Clinical Trials at Genentech Susanne Prokscha Principal CDM PTM Process Analyst February 2012.
Molecule-to-Market-Place Quality
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
University of Minnesota Internal\External Sales “The Internal Sales Review Process” An Overview of What Happens During the Review.
1 Project Management C13PM Session 2 Project Initiation & Definition Russell Taylor Business Department Staff Workroom
Illuminating Britelite’s Internal Services for Success Strategy for Process Improvement.
Quality & Regulatory Expectations of Outsourcing Oversight Nicky Dodsworth, VP Global Quality Assurance.
Patricia Alafaireet Patricia E. Alafaireet, PhD Director of Applied Health Informatics University of Missouri-School of Medicine Department of Health.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
IS&T Project Reviews September 9, Project Review Overview Facilitative approach that actively engages a number of key project staff and senior IS&T.
GCP (GOOD CLINICAL PRACTISE)
Business Considerations in eTMF Implementation Karen Roy Phlexglobal Ltd.
Regulatory Intelligence for the Emerging Markets Lisa Rysso-DeMaggio President, RAQUELIAN Consulting DIA Regulatory Intelligence Working Group, 10 Sep.
Responsibilities of Sponsor, Investigator and Monitor
Project Management PTM721S
Responsibilities of Sponsor, Investigator and Monitor
ISO/IEC
Systems Analysis and Design in a Changing World, 4th Edition
CLINICAL DATA MANAGEMENT
Description of Revision
11 iii. Define management and supervision roles and responsibilities
Discrepancy Management
REAL WORLD CASE STUDY.
Code of Ethics for CDM Professionals
{Project Name} Organizational Chart, Roles and Responsibilities
Code of Ethics for CDM Professionals
Presentation transcript:

Enhancing the CRO-Sponsor Collaboration to Ensure High Quality of Clinical Data May 17,2011 | Beijing, China Charles Yan, PhD Shanghai Clinical Research Center

2www.diahome.orgDrug Information Association Potential Advantages and Risks for Outsourcing Outsourcing for Clinical Data Management Considerations in Selecting a CRO Key Factors for High Data Quality Best Outsourcing Relationship Agenda

3www.diahome.orgDrug Information Association Reduce: –Time to develop and commercialize a new drug –Sponsor’s fixed costs with personnel, equipment and facilities needed for its clinical development Provide: –Ready access to needed expertise and/or technology –Greater access to potential investigators –Knowledge of regulatory climate in foreign markets Potential Advantages for CROs

4 Reduced control of the clinical trial process by the Sponsor –Delays in completion of studies –Lost or poor data quality –Regulatory infractions produce indirect consequences FDA regulations/GCPs Fraud and Abuse –IP Potential Risks of Outsourcing to CROs

5www.diahome.orgDrug Information Association Data Management Plan CRF Design, Annotated CRF Database Setup and Edit Check Development Data Entry and Discrepancy Management Lab Data Management AE/SAE Management Coding (MedDRA + WHO DD) Database Locking QC and QA Outsourcing for Clinical Data Management Electronic Data Capture Site User Training, Administration and Support EDC : Site Guides

6www.diahome.orgDrug Information Association Company information – Historical overview of the organization, – Length of time in the industry, – Financial stability of the organization – Organizational structure Products and services Experience Product demonstration Commercial – Business sustainability – Cost of services Considerations in Selecting a CRO

7www.diahome.orgDrug Information Association Compliance – Understanding of global regulations(FDA, SFDA, etc) – Archiving system – Quality systems and proof of compliance to their quality requirements – Quality assurance Documentation of system validation for regulated processes Evaluation of the vendor’s QC/QA process Disaster/contingency plan(s) to protect business operations Adaptation to sponsor’s SOPs Results of previous regulatory inspections Considerations in Selecting a CRO

8www.diahome.orgDrug Information Association Capacity and Flexibility – Expansion with changing needs – Resources to deal with uncertainties – Handling additional assignments Capability and Credibility – Diversity of experience – Experienced people – Adequate facilities – Training and incentives for people Confidentiality Considerations in Selecting a CRO

9www.diahome.orgDrug Information Association Documentation change control processes Review of required accreditation Personnel qualification, job descriptions, organizational charts, training plans etc. Data transfer process References from previous customers Outcomes of previous regulatory inspections Security of physical locations where services are provided (server rooms, file rooms, etc.) The number of sponsors or studies currently supported by the available CRO staff Considerations in Selecting a CRO

– Overview of the whole program – Ensure that processes for both companies are described in detail (SOPs and training) – Define the roles and responsibilities for sponsor and CRO – Discuss expectations of both teams in regard to deliverables, timelines and resource – Communication and decision-making strategy – Issue resolution process – Budget planning and management – Expectations and performance metrics 10 Key Factors for High Data Quality Detailed start-up meetings ( face-to-face )

In recent industry survey, both Sponsor and CRO agree that the top sources of conflict are related to mismatched expectations. – Pharma: 88% agree – Service Providers: 92% agree 11www.diahome.orgDrug Information Association The Most Common Sources of Conflict For SponsorFor CRO Expected innovation does not materializeExpected volumes do not materialize Scope changes lead to additional costsChanges in requirements lead to increased & unrecoverable costs Off-contract purchasing undermines expected savings Customer does not provide committed resources Project delays due to supplierProject delays due to customer Quality problems Key Factors for High Data Quality

12www.diahome.orgDrug Information Association Define Acceptable Metrics in Data Management ( Time, Cost, Quality and Quantity) Data Management ProcessKPI Study prepare phase—CRF design duration —Database setup duration Study conduct—CRF received->Data entry —Data entered -> query generated —Query generated-> query reviewed —Query resolution time —LPLV-> database lock Study closeout—Error Rate (data entry, CRF vs database) Key Factors for High Data Quality

To clearly define the roles and responsibilities for DM CRO 13www.diahome.orgDrug Information Association At Study Setup Phase Data Management Task DescriptionSponsorCRO Data Management Plan CRF Design and Annotated CRF Database Setup Validation Program CRF tracking Data Entry Discrepancy Management Coding (MedDRA or WHO DD or both)... Key Factors for High Data Quality

To have a good communication channels (weekly basis or as needed) 14www.diahome.orgDrug Information Association At Study Conduct Phase CROSponsor Report any findings during study conductDecision maker on any issues reported Or approval for the actions Submit weekly progress report ―Summary data quality ―CRF pages received ―CRF pages entered/cleaned ―Missing and/or expected CRFs ―Queries sent/outstanding/resolved As reviewer ―Focus on QA or QC ―Safety and efficacy data Interim AnalysisTimeline Key Factors for High Data Quality

To follow database lock procedures and to lock database on time 15www.diahome.orgDrug Information Association At Study Closeout Phase CROSponsor Database lockTimeline for Database lock Prepare DB lock checklist ―All data entered ―Any open query ―SAE reconciliation ―Coding ―QC ―… —Special query handling —Data quality review —SAE reconciliation resolving —Database locking approval Lock database and dataset transferring Check all docs completed and signed ―Paper CRF ―Datasets ―DMP ―… Key Factors for High Data Quality

16www.diahome.orgDrug Information Association Understand, learn and respect each other –Careful selection and detailed contract vital for a long term successful relationship –Sponsors need to carefully assess the requirements of CRO –CRO needs to understand expectations of sponsor –Mutual benefit from the relationship –Support from senior management Set measurable goals and objectives –Performance measurement and feedback –Periodic, formal and fact-based relationship –Progress review process in place Communications and conflict resolution process Feedback and evaluation Best Outsourcing Relationship

17www.diahome.orgDrug Information Association Thank you! Q&A Contact info: